Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 18.55
+0.16 (0.87%)
Oct 23, 2026, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 7.48 billion as of October 22, 2026. It is the 9,481st most valuable company in the world and the 2,024th biggest in China. Its market cap has decreased by 15.99% in one year.
Market Cap
7.48B
Enterprise Value
7.73B
Revenue
1.70B
Global Rank
Country Rank
#2,024 China
PE Ratio
20.36
ChartMarket Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 7.48B, an increase of 54.87%. That is a compound annual growth rate of 7.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 7.48B | -26.46% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 8.62B |
| Liaoning Chengda Biotechnology | 8.32B |
| Novogene | 8.20B |
| Vcanbio Cell & Gene Engineering Corp., | 8.16B |
| Chengdu Easton Biopharmaceuticals | 8.14B |
| Daan Gene | 7.92B |
| Jiangxi Fushine Pharmaceutical | 7.85B |
| Bio-Thera Solutions | 7.41B |